Z. Yao et al., HLA CLASS-II GENES AND ANTIBODIES AGAINST RECOMBINANT U1-NRNP PROTEINS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Rheumatology international, 14(2), 1994, pp. 63-69
To investigate a possible involvement of HLA-class II alleles in the g
enetic predisposition for the formation of anti-U1-nRNP antibody in sy
stemic lupus erythematosus (SLE), genomic DNA of 178 patients was type
d for the DRB1, DQA1 and DQB1 alleles using a polymerase chain reactio
n (PCR) and non-radioactive-oligonucleotide typing. Antibodies against
recombinant U1-nRNP proteins (U1-A-, U1-C- and 70K-protein) were dete
rmined by ELISA. Anti-U1-C antibody was found in 26 (14.7%), anti-U1-A
in 34 (19.2%) and anti-70K in 17 (9.6%) patients. A joint occurrence
was observed for these antibodies against the recombinant U1-nRNP prot
eins: anti-U1-C and anti-U1-A antibodies occurred together more freque
ntly than alone and than together with anti-U1-70K antibodies. The fre
quency of DRB104 was slightly increased in the patients with anti-U1-
C as compared to the patients without anti-U1-C (P<0.05, Pcorr = n.s.,
RR = 2.4). The DQA10301 allele, which is in linkage disequilibrium w
ith DRB104, is found more frequently in anti-U1-C-positive than in an
tibody-negative patients. The DQB10303 allele, detected in 12 of 176
SLE patients, was absent in the patients with any of the antibodies ag
ainst the U1-nRNP proteins. All these deviations may be due to chance
alone. We concluded that the presence of antibodies against recombinan
t U1-nRNP proteins was not significantly associated with any HLA DRB1,
DQA1 and DQB1 allele in our group of SLE patients.